Capitolis Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-502,000
Closed -$89.1M 96
2022
Q2
$89.1M Sell
502,000
-1,606
-0.3% -$286K 4.66% 4
2022
Q1
$89.3M Sell
503,606
-241,131
-32% -$41M 4.49% 6
2021
Q4
$127M Buy
744,737
+33,286
+5% +$5.45M 0.76% 29
2021
Q3
$114M Buy
711,451
+71,607
+11% +$12.2M 1.04% 22
2021
Q2
$105M Buy
639,844
+213,527
+50% +$35.4M 1.24% 16
2021
Q1
$70.1M Sell
426,317
-234,635
-35% -$38M 1.21% 17
2020
Q4
$104M Buy
+660,952
New +$97.5M 1.74% 9

Other funds holding JNJ

Capitolis Advisors's JNJ Position: Q3 2022 in Review

Capitolis Advisors sold out of Johnson & Johnson (JNJ) in Q3 2022, closing a stake of 502,000 shares — an estimated $89.1M sold.

Capitolis Advisors first reported a position in JNJ in Q4 2020 and held it in 7 quarters. The position peaked at $127M in Q4 2021. 3,622 funds tracked by Wall St. Rank hold JNJ as of Q3 2022.

  • Capitolis Advisors reported no remaining Johnson & Johnson position as of Q3 2022 after selling out during the quarter.
  • Capitolis Advisors sold 502,000 Johnson & Johnson shares in Q3 2022, an estimated $89.1M.
  • Capitolis Advisors first reported a position in Johnson & Johnson in Q4 2020 and held it in 7 quarters.
  • Capitolis Advisors's Johnson & Johnson position peaked at $127M in Q4 2021.
  • 3,622 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2022.

Based on Capitolis Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.